196 related articles for article (PubMed ID: 26285704)
21. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
Hulgan T; Shepherd BE; Raffanti SP; Fusco JS; Beckerman R; Barkanic G; Sterling TR
J Infect Dis; 2007 Feb; 195(3):425-31. PubMed ID: 17205482
[TBL] [Abstract][Full Text] [Related]
22. Effect of zinc and multivitamin supplementation on the growth of Tanzanian children aged 6-84 wk: a randomized, placebo-controlled, double-blind trial.
Locks LM; Manji KP; McDonald CM; Kupka R; Kisenge R; Aboud S; Wang M; Fawzi WW; Duggan CP
Am J Clin Nutr; 2016 Mar; 103(3):910-8. PubMed ID: 26817503
[TBL] [Abstract][Full Text] [Related]
23. Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study).
Serrano-Villar S; de Lagarde M; Vázquez-Castellanos J; Vallejo A; Bernadino JI; Madrid N; Matarranz M; Díaz-Santiago A; Gutiérrez C; Cabello A; Villar-García J; Blanco JR; Bisbal O; Sainz T; Moya A; Moreno S; Gosalbes MJ; Estrada V
Clin Infect Dis; 2019 Jan; 68(1):120-130. PubMed ID: 29788075
[TBL] [Abstract][Full Text] [Related]
24. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
Seyoum A; Ndlovu P; Temesgen Z
AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
[TBL] [Abstract][Full Text] [Related]
25. High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.
Stallings VA; Schall JI; Hediger ML; Zemel BS; Tuluc F; Dougherty KA; Samuel JL; Rutstein RM
Pediatr Infect Dis J; 2015 Feb; 34(2):e32-40. PubMed ID: 24988118
[TBL] [Abstract][Full Text] [Related]
26. Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection.
Jariwalla RJ; Lalezari J; Cenko D; Mansour SE; Kumar A; Gangapurkar B; Nakamura D
J Altern Complement Med; 2008 Mar; 14(2):139-46. PubMed ID: 18315507
[TBL] [Abstract][Full Text] [Related]
27. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
Chege D; Kovacs C; la Porte C; Ostrowski M; Raboud J; Su D; Kandel G; Brunetta J; Kim CJ; Sheth PM; Kaul R; Loutfy MR
AIDS; 2012 Jan; 26(2):167-74. PubMed ID: 22089379
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial to determine the optimal dosage of multivitamin supplements to reduce adverse pregnancy outcomes among HIV-infected women in Tanzania.
Kawai K; Kupka R; Mugusi F; Aboud S; Okuma J; Villamor E; Spiegelman D; Fawzi WW
Am J Clin Nutr; 2010 Feb; 91(2):391-7. PubMed ID: 19939985
[TBL] [Abstract][Full Text] [Related]
29. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
Peters BS; Wierzbicki AS; Moyle G; Nair D; Brockmeyer N
Clin Ther; 2012 Jan; 34(1):67-76. PubMed ID: 22212377
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.
ENCORE1 Study Group
Lancet; 2014 Apr; 383(9927):1474-1482. PubMed ID: 24522178
[TBL] [Abstract][Full Text] [Related]
31. Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial.
Kelly P; Katubulushi M; Todd J; Banda R; Yambayamba V; Fwoloshi M; Zulu I; Kafwembe E; Yavwa F; Sanderson IR; Tomkins A
Am J Clin Nutr; 2008 Oct; 88(4):1010-7. PubMed ID: 18842788
[TBL] [Abstract][Full Text] [Related]
32. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda.
Stangl AL; Wamai N; Mermin J; Awor AC; Bunnell RE
AIDS Care; 2007 May; 19(5):626-36. PubMed ID: 17505923
[TBL] [Abstract][Full Text] [Related]
33. Short-term folinic acid supplementation improves vascular reactivity in HIV-infected individuals: a randomized trial.
Grigoletti SS; Guindani G; Moraes RS; Ribeiro JP; Sprinz E
Nutrition; 2013 Jun; 29(6):886-91. PubMed ID: 23660169
[TBL] [Abstract][Full Text] [Related]
34. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.
Sutinen J; Walker UA; Sevastianova K; Klinker H; Häkkinen AM; Ristola M; Yki-Järvinen H
Antivir Ther; 2007; 12(1):97-105. PubMed ID: 17503753
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.
; Carey D; Puls R; Amin J; Losso M; Phanupak P; Foulkes S; Mohapi L; Crabtree-Ramirez B; Jessen H; Kumar S; Winston A; Lee MP; Belloso W; Cooper DA; Emery S
Lancet Infect Dis; 2015 Jul; 15(7):793-802. PubMed ID: 25877963
[TBL] [Abstract][Full Text] [Related]
36. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
37. Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.
Lalezari JP; Beal JA; Ruane PJ; Cohen CJ; Jacobson EL; Sundin D; Leong WP; Raffanti SP; Wheeler DA; Anderson RD; Keiser P; Schrader SR; Goodgame JC; Steinhart CR; Murphy RL; Wolin MJ; Smith KA
HIV Clin Trials; 2000; 1(3):1-15. PubMed ID: 11590500
[TBL] [Abstract][Full Text] [Related]
38. Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study.
Ezeamama AE; Guwatudde D; Wang M; Bagenda D; Kyeyune R; Sudfeld C; Manabe YC; Fawzi WW
Clin Nutr; 2016 Oct; 35(5):1110-7. PubMed ID: 26371397
[TBL] [Abstract][Full Text] [Related]
39. Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.
Miró JM; Manzardo C; Pich J; Domingo P; Ferrer E; Arribas JR; Ribera E; Arrizabalaga J; Loncá M; Cruceta A; de Lazzari E; Fuster M; Podzamczer D; Plana M; Gatell JM;
AIDS Res Hum Retroviruses; 2010 Jul; 26(7):747-57. PubMed ID: 20624069
[TBL] [Abstract][Full Text] [Related]
40. Multivitamin therapy for recurrent aphthous stomatitis: a randomized, double-masked, placebo-controlled trial.
Lalla RV; Choquette LE; Feinn RS; Zawistowski H; Latortue MC; Kelly ET; Baccaglini L
J Am Dent Assoc; 2012 Apr; 143(4):370-6. PubMed ID: 22467697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
